PIK3IP1-AS1: Key regulator of cell signaling pathways and disease interactions

Target Name: PIK3IP1-DT

NCBI ID: G101929760

PIK3IP1-DT

Other Name(s): PIK3IP1-AS1 | PIK3IP1 divergent transcript

PIK3IP1-AS1: Key regulator of cell signaling pathways and disease interactions

The protein PIK3IP1-AS1 (Protein-Protein Interaction gene 3-AS1) is a key regulator of cell signaling pathways, particularly in the insulin/IGF-1 signaling pathway. This pathway plays a crucial role in the regulation of various cellular processes, including growth, differentiation, and metabolism. The protein encoded by PIK3IP1-AS1 has been shown to interact with multiple partner proteins, including PTEN, TCF7L1, and EID1. Despite the importance of this protein in cellular signaling, its role in disease pathology is not well understood.

Disease-Related Interactions with PIK3IP1-AS1

Several studies have identified potential disease-related interactions with PIK3IP1-AS1. One of the most significant findings is the association of PIK3IP1-AS1 with various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

1. Cancer

Studies have shown that PIK3IP1-AS1 is involved in the regulation of various cellular processes that are critical for cancer development, including cell growth, apoptosis, and angiogenesis. For example, PIK3IP1-AS1 has been shown to play a role in the regulation of cell cycle progression and the execution of apoptosis in cancer cells. Additionally, PIK3IP1-AS1 has been shown to promote the angiogenic process, which is the process by which cancer cells promote the formation of new blood vessels to supply themselves with oxygen and nutrients.

2. Neurodegenerative Diseases

Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles and neurodegeneration. PIK3IP1-AS1 has been shown to be involved in the regulation of several key events that are associated with neurodegenerative diseases, including the regulation of neurotransmitter synthesis and the modulation of pain perception.

3. Autoimmune Diseases

Autoimmune diseases, such as rheumatoid arthritis, lupus, and multiple sclerosis, are characterized by the immune system attacking the body's own tissues and organs. PIK3IP1-AS1 has been shown to be involved in the regulation of several key events that are associated with autoimmune diseases, including the regulation of immune cell function and the modulation of inflammation.

4. Pregnancy and Fertility

Pregnancy and fertility are areas of significant interest for the study of PIK3IP1-AS1, as the regulation of this protein has been shown to play a critical role in these processes. Studies have shown that PIK3IP1-AS1 is involved in the regulation of early fetal development, including the regulation of neural tube formation and the establishment of a normal circadian rhythm. Additionally, PIK3IP1-AS1 has been shown to play a role in the regulation of fertility, including the regulation of sperm motility and the female reproductive system.

Conclusion

In conclusion, PIK3IP1-AS1 is a protein that has been shown to play a critical role in several cellular processes, including cell signaling pathways, cancer, neurodegenerative diseases, and autoimmune diseases. The regulation of PIK3IP1-AS1 has been shown to be associated with the development and progression of various diseases, including cancer, neurodegenerative diseases, autoimmune diseases, and pregnancy and fertility. Further research is needed to fully understand the role of PIK3IP1-AS1 in disease pathology and to identify potential therapeutic targets.

Protein Name: PIK3IP1 Divergent Transcript

The "PIK3IP1-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIK3IP1-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets